English
Italiano
Deutsch
日本語
中文
Español
It's now available on-demand Stevanato Group with Duoject Medical Systems and IQVIA webinar on:
Missed the live presentation? Enjoy now the webinar available on-demand!
The global auto-injector market is expected to witness massive growth by 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, a shift towards self-administration, and technological advancements. The patent expiry of biologics is also expected to provide growth opportunities for players in the market.
This webinar will provide an overview of the factors driving growth in the auto-injector space, examine the challenges, opportunities, and evolving technologies for a safer, more efficient, and patient-friendly emergency auto-injector platform.
Drug Delivery Systems Product Manager, Stevanato Group
Adam Stops is Drug Delivery Systems Product Manager at Stevanato Group, managing auto-injectors, pre-filled variable, fixed-dose pen injectors, large-volume wearable injectors, and inhalers.
Boasting a Ph.D. in Mechanical Engineering and an MBA in business management, Adam Stops has a broad experience in the design, development, and product management of devices and parenteral products.
He has worked with innovative multinational companies leading teams of experts in device research, design, and industrialization throughout his career.
Consultant, Thought Leadership, IQVIA
Yasemin is a Consultant in the European Thought Leadership team based in IQVIA’s London office. Her primary areas of focus are; trends in innovative launches as well as the oncology market, with emphasis on clinical and commercial trends.
Yasemin holds a Masters in Cancer Research and a Bachelor of Science degree in Biomedical Sciences, both from Newcastle University.
Prior to her role in Thought Leadership, Yasemin was part of the Real-World Insights – Global Oncology team, where she worked on the co-ordination and set-up of reports focusing on various cancers.
Vice President Engineering, Duoject Medical Systems
Daniel MacDonald is Vice-President of Engineering Services at Duoject Medical Systems, an innovative drug delivery systems development company. Duoject is part of Novocol Pharma, a leading cartridge fill-finish CDMO.
With a degree in Mechanical Engineering and a specialty in Design from Polytechnique in Montréal, Dan has been with Duoject for over 25 years, holding various positions and working his way up to his current role.
Dan holds numerous patents in the medical device field and currently oversees the Design and Engineering teams, while also supporting key business development activities worldwide.